Cochrane Abstracts
Platinum‐based chemotherapy for early triple‐negative breast cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Platinum‐based Chemotherapy for Early Triple‐negative Breast Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431354/all/Platinum‐based_chemotherapy_for_early_triple‐negative_breast_cancer.
Platinum‐based chemotherapy for early triple‐negative breast cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431354/all/Platinum‐based_chemotherapy_for_early_triple‐negative_breast_cancer. Accessed November 22, 2024.
Platinum‐based chemotherapy for early triple‐negative breast cancer. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431354/all/Platinum‐based_chemotherapy_for_early_triple‐negative_breast_cancer
Platinum‐based Chemotherapy for Early Triple‐negative Breast Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431354/all/Platinum‐based_chemotherapy_for_early_triple‐negative_breast_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Platinum‐based chemotherapy for early triple‐negative breast cancer
ID - 431354
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431354/all/Platinum‐based_chemotherapy_for_early_triple‐negative_breast_cancer
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
